Home/ Supplements/ Vitamin A/ DAYAVITE

DAYAVITE

product on market Tablet or Pill Amella Pharma Safety: 98/100
98/100

This product looks safe

  • Folate: 1666mg is 1666.0× the Tolerable Upper Intake Level (1.0mg)
  • 75% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formulation includes essential vitamins A, C, D, E, and thiamine, which are supported by strong evidence for maintaining immune function and cellular health. These nutrients play established roles in antioxidant protection and metabolic processes. However, overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 1666mg is 1666.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for DAYAVITE
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
75%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
750 mcg (23% DV)
Vitamin C
75 mg (83% DV)
25 mcg (125% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
20.1 mg (134% DV)
1.3× RDA — within safe limits 179 studies (A:3, B:90)
15 mg (1250% DV)
12.5× RDA — above typical dose 76 studies (A:0, B:33)
15 mg (1154% DV)
11.5× RDA — above typical dose 13 studies (A:0, B:1)
20 mg (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
17.5 mg (1029% DV)
13.5× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
1666 mcg DFE (417% DV)
Exceeds UL by 1666.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
50 mcg (2083% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
75 mcg (50% DV)
Within RDA (0.5× RDA) 245 studies (A:4, B:133)
200 mg (48% DV)
Within RDA (0.5× RDA) 316 studies (A:8, B:159)
7.5 mg (68% DV)
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
35 mcg (64% DV)
Within RDA (0.6× RDA) 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
2.5 mg (109% DV)
1.1× RDA — within safe limits 9 studies — no high-quality reviews
100 mcg (286% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
37.5 mcg (83% DV)
Within RDA (0.8× RDA) 3 studies — no high-quality reviews
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

Croscarmellose Sodium Polyvinyl alcohol Polyethylene Glycol Titanium Dioxide Talc FD&C Red #40 FD&C Yellow #6 Stearic Acid Calcium Carbonate Pharmaceutical Glaze Microcrystalline Cellulose Magnesium Stearate Mono-and Diglycerides Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Usual dosage: Usual adult dose is 1 tablet by mouth once daily or as prescribed by a licensed medical practitioner.

Warnings & Precautions

If you are pregnant or nursing, ask a healthcare professional prior to using.

Consult your physician immediately if adverse side effects occur.

Keep out of the reach of children.

Additional Information

Storage: Store at 20 degrees to 25 degrees C (68 degrees to 77 degrees F;) excursions permitted to 15 degrees to 30 degrees (59 degrees to 86 degrees F) [See USP controlled room temperature]

72287-0663-30 Rx only

Metadata

Product Details

UPC / SKU3 72287 66330 9
DSLD Entry Date2021-11-19
Product TypeOther Combinations
FormTablet or Pill
DSLD ID263286
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.